Terri Wrin

University of North Carolina at Chapel Hill — United States

Immunology and Microbiology · Life Sciences

65h-index19.7kcitations162works7.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(119), HIV/AIDS drug development and treatment(72), HIV/AIDS Research and Interventions(41), Immune Cell Function and Interaction(29), SARS-CoV-2 and COVID-19 Research(28)

Publications158 total

Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 clades
Journal of Virology·2025Open Access
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections
JCI Insight·2025Open Access
Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals”
UNC Libraries·2025Open Access
A Phase I/II Randomized Trial of Higher Dose mRNA-1273 Boosters in Lung Transplant Recipients
OBM Transplantation·2024Open Access
The effect of circulating neutralizing antibodies on the replication of SARS-CoV-2 variants following post-vaccination infections
2024Open Access
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies
Molecular Therapy — Methods & Clinical Development·2024· 43 citedOpen Access
SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk
Journal of Perinatology·2023· 6 cited
The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptoms
Journal of Medical Virology·2023· 8 citedOpen Access
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland
The Lancet Microbe·2023· 9 citedOpen Access
SARS-CoV-2 Neutralizing Antibody Titers in Maternal Blood, Umbilical Cord Blood, and Breast Milk
2023· 3 citedOpen Access
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
2023· 2 citedOpen Access
Global seroprevalence of neutralizing antibodies against adeno-associated virus (AAV) serotypes of relevance to gene therapy
Hämostaseologie·2023· 1 cited
Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report
Vaccines·2022· 46 citedOpen Access
Global Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Serotypes of Relevance to Gene Therapy
Blood·2022· 4 cited
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection
Microbiology Spectrum·2022· 18 citedOpen Access
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Nature Communications·2022· 38 citedOpen Access
Multiple early factors anticipate post-acute COVID-19 sequelae
Cell·2022· 1.1k citedOpen Access
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
Scientific Reports·2021· 74 citedOpen Access
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates Against Symptomatic Infection
2021· 2 citedOpen Access
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Nature Medicine·2021· 1.2k citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Christos J. Petropoulos(28), Pascal Poignard(9), Dennis R. Burton(9), Steven G. Deeks(9), Rebecca Hoh(6), Hanneke Schuitemaker(6), Alejandra Ramos(5), Douglas D. Richman(5), Colombe Chappey(5), Robert M. Grant(5), Ellen E. Paxinos(5), Simon D. W. Frost(5), Jeffrey N. Martin(5), Laura M. Walker(4), Pham Phung(4), Melissa Simek(4), Susan J. Little(4), Jason D. Barbour(4), Nicholas S. Hellmann(4), Joseph M. McCune(4)